News Nov 21, 2023 Interview with HYCON GmbH HYCON is a Swiss-based company of consultants and engineers focusing on renewable energy, WASH (water, sanitation and hygiene), land management, ...
News Dec 13, 2022 New Empa method indicates virus death in face masks With the help of a method developed at the Swiss Federal Laboratories for Materials Science and Technology (Empa), researchers can compare which ...
News May 23, 2023 University of Basel and RocketVax present new COVID vaccine Researchers from the University of Basel have developed a new concept for a COVID vaccine in collaboration with the biotech start-up RocketVax. I...
Aktuell May 23, 2023 Universität Basel und RocketVax stellen neuen COVID-Impfstoff vor Forschende der Universität Basel haben mit dem Biotech-Start-up RocketVax ein neues Konzept für einen Corona-Impfstoff entwickelt. Er beruht auf ...
Aktuell Mar 18, 2020 Trump lobt Coronavirus-Test von Roche Die US-amerikanische Zulassungsbehörde hat einen Test der Basler Pharmafirma Roche für das Virus SARS-CoV 2 zugelassen. Durch die Arbeit von Roch...
News Nov 18, 2020 Lonza manufactures coronavirus vaccine for Moderna Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of the year. Moderna published the initial results...
News Jun 05, 2020 Not just coronavirus: An overview of important export topics from recent weeks Alongside COVID-19, decrees have been made and decisions taken in other areas that are of relevance for international business: An overview of ke...
Novità Jun 09, 2020 Non solo coronavirus: una panoramica sui più importanti temi delle ultime settimane legati alle esportazioni Oltre a quelle relative al COVID-19, sono state adottate ordinanze e decisioni anche in altre aree tematiche rilevanti per il commercio internazi...
News Oct 19, 2020 Zurich remains attractive to investors despite coronavirus Venture capital investments have declined throughout Europe during the coronavirus crisis. However, a completely different picture emerges in rel...
News Sep 16, 2020 Lonza set to manufacture coronavirus drug for Humanigen The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonz...
News Sep 07, 2020 Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that simultaneously tests...
News Mar 26, 2020 Reusable masks to fight coronavirus: a Swiss start-up has the solution Swoxid, a cleantech start-up spun from the Laboratory of Physics of Complex Matter at the Swiss Federal Institute of Technology in Lausanne, has ...
News Aug 21, 2020 Researchers develop novel approach against the coronavirus The Swiss National Science Foundation is funding a novel approach for a coronavirus vaccine. This approach developed by virologist Cornel Fraefel...
News Sep 18, 2020 Crypto Valley thriving despite coronavirus crisis The number of companies in Switzerland and Liechtenstein working on blockchain technologies increased to 919 in the first half of the year. They ...
Aktuell May 27, 2020 Celonic bekämpft Coronavirus mit Kooperation Die Basler Biopharmafirma Celonic Group hat eine Zusammenarbeit mit der amerikanischen Airway Therapeutics vereinbart. Gemeinsam wollen beiden Fi...
News May 27, 2020 Celonic agrees cooperation to combat coronavirus The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two compani...
Aktuell Mar 30, 2020 Universität Basel sucht Wirkstoff gegen Coronavirus Die Universität Basel setzt bei ihrer Suche nach einem Wirkstoff gegen das Coronavirus auf computergestützte Methoden. So sind bereits knapp 700 ...
